- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07575425
Effects of Mobilized Balance Platform Exercises on Balance Parameters in Patients With Knee Osteoarthritis
Effects of Mobilized Balance Platform Exercises on Balance Parameters, Functional Status, and Pain in Patients With Knee Osteoarthritis: A Randomized Controlled Trial
This prospective single-blind randomized controlled study aims to investigate the effects of mobilized balance platform exercises on balance parameters, pain, functional status, fear of falling, and kinesiophobia in patients with knee osteoarthritis. A total of 36 patients diagnosed with knee osteoarthritis will be recruited from the outpatient clinic of Gaziler Physical Medicine and Rehabilitation Training and Research Hospital.
Participants will be randomly assigned to one of two groups. The control group will receive conventional physical therapy including transcutaneous electrical nerve stimulation (TENS) and a home exercise program consisting of knee strengthening, balance, range of motion, proprioceptive, and stretching exercises. The intervention group will receive the same conventional treatment in addition to mobilized balance platform exercises using the Huber 360 system.
Pain severity, functional status, balance parameters, fear of falling, and kinesiophobia will be evaluated before and after treatment by an assessor blinded to treatment allocation.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Sefa Gumruk Aslan
- Telefoonnummer: +903122911503
- E-mail: sefagumrukk@gmail.com
Studie Locaties
-
-
-
Ankara, Turkije (Türkiye)
- Werving
- Gaziler physical therapy and rehabilitation
-
Contact:
- Sefa Gumruk Aslan
- Telefoonnummer: +903122911503
- E-mail: sefagumrukk@gmail.com
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Patients aged between 45 and 65 years
- Diagnosis of knee osteoarthritis classified as Kellgren-Lawrence grade 2 or 3
- Willingness to participate voluntarily in the study
Exclusion Criteria:
- Presence of orthopedic knee implants
- Kellgren-Lawrence grade 1 or grade 4 knee osteoarthritis
- Sensory impairment
- Diagnosis of malignancy
- Unhealed fractures
- Circulatory disorders
- Infection around the knee joint
- Severe hearing loss or visual impairment
- Cognitive impairment
- Uncontrolled hypertension or diabetes mellitus
- Vestibular disorders causing balance problems, such as vertigo
- Use of walking assistive devices such as canes or walkers
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Actieve vergelijker: Conventional Physical Therapy
Participants in this group will receive conventional physical therapy including transcutaneous electrical nerve stimulation (TENS) and a home exercise program.
The home exercise program will include knee strengthening, balance, range of motion, proprioceptive, and stretching exercises, performed 3 days per week for 20 minutes.
|
Participants will receive conventional physical therapy including transcutaneous electrical nerve stimulation (TENS) and a home exercise program consisting of knee strengthening, balance, range of motion, proprioceptive, and stretching exercises performed 3 times per week for 20 minutes.
|
|
Experimenteel: Mobilized Balance Platform Exercise
Participants in this group will receive conventional physical therapy including TENS in addition to mobilized balance platform exercises using the Huber 360 system.
The exercise protocol will include quadriceps and core strengthening, proprioceptive, balance, and neuromuscular exercises, performed 3 days per week for 20 minutes.
|
Participants will receive conventional physical therapy including transcutaneous electrical nerve stimulation (TENS) and a home exercise program consisting of knee strengthening, balance, range of motion, proprioceptive, and stretching exercises performed 3 times per week for 20 minutes.
Participants will perform mobilized balance platform exercises using the Huber 360 system.
The exercise protocol will include quadriceps and core strengthening, proprioceptive training, balance exercises, and neuromuscular exercises specifically designed for patients with knee osteoarthritis.
Sessions will be performed 3 times per week for 20 minutes.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Static and Dynamic Balance Parameters
Tijdsspanne: Before treatment and immediately after completion of the 8-week treatment program
|
Balance performance will be assessed using the Huber 360 balance assessment system.
Measurements will include static balance with eyes open and eyes closed, single-leg balance performance, and limits of stability.
|
Before treatment and immediately after completion of the 8-week treatment program
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Pain Severity Assessed by Visual Analog Scale (VAS)
Tijdsspanne: Before treatment and immediately after completion of the 8-week treatment program
|
Pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS) for night pain, resting pain, and pain during movement.
Higher scores indicate greater pain severity.
|
Before treatment and immediately after completion of the 8-week treatment program
|
|
Functional Status Assessed by WOMAC
Tijdsspanne: Before treatment and immediately after completion of the 8-week treatment program
|
Functional status will be evaluated using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC).
Higher scores indicate worse pain, stiffness, and functional limitation.
|
Before treatment and immediately after completion of the 8-week treatment program
|
|
Functional Mobility Assessed by Timed Up and Go Test
Tijdsspanne: Before treatment and immediately after completion of the 8-week treatment program
|
Functional mobility and dynamic balance will be assessed using the Timed Up and Go Test.
Shorter completion times indicate better functional mobility.
|
Before treatment and immediately after completion of the 8-week treatment program
|
|
Fear of Falling Assessed by the International Falls Efficacy Scale
Tijdsspanne: Before treatment and immediately after completion of the 8-week treatment program
|
Fear of falling during activities of daily living will be evaluated using the International Falls Efficacy Scale.
Higher scores indicate greater concern about falling.
|
Before treatment and immediately after completion of the 8-week treatment program
|
|
Kinesiophobia Assessed by Tampa Scale for Kinesiophobia
Tijdsspanne: Before treatment and immediately after completion of the 8-week treatment program
|
Fear of movement and reinjury will be evaluated using the Tampa Scale for Kinesiophobia.
Higher scores indicate greater fear of movement.
|
Before treatment and immediately after completion of the 8-week treatment program
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: Sefa Gümrük Aslan, gaziler physcial therapy and rehabilitation hospital
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- KOA-MBP-2026
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .